• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    FDA Approval for EZETIMIBE AND SIMVASTATIN

    2/25/21 5:09:42 AM ET
    $ANIP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ANIP alert in real time by email
    Abbreviated New Drug Application (ANDA): 201890
    Company: ANI PHARMS INC
    • Email

    Products on ANDA 201890

    Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
    EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;10MG TABLET;ORAL Prescription AB No No
    EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;20MG TABLET;ORAL Prescription AB No No
    EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;40MG TABLET;ORAL Prescription AB No No
    EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;80MG TABLET;ORAL Prescription AB No No

    Approval Date(s) and History, Letters, Labels, Reviews for ANDA 201890

    Original Approvals or Tentative Approvals
    Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
    04/26/2017 ORIG-1 Approval Not Applicable

    Label is not available on this site.

    Supplements
    Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
    02/23/2021 SUPPL-10 Labeling-Package Insert, Labeling-Patient Package Insert

    Label is not available on this site.

    01/29/2020 SUPPL-9 Labeling-Patient Package Insert, Labeling-Package Insert

    Label is not available on this site.

    01/29/2020 SUPPL-8 Labeling-Patient Package Insert, Labeling-Package Insert

    Label is not available on this site.

    04/02/2019 SUPPL-5 Labeling-Package Insert

    Label is not available on this site.

    Therapeutic Equivalents for ANDA 201890

    EZETIMIBE AND SIMVASTATIN

    TABLET;ORAL; 10MG;10MG
    TE Code = AB

    Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
    EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;10MG TABLET;ORAL Prescription No AB 209222 ALKEM LABS LTD
    EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;10MG TABLET;ORAL Prescription No AB 208831 AMNEAL PHARMS CO
    EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;10MG TABLET;ORAL Prescription No AB 201890 ANI PHARMS INC
    EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;10MG TABLET;ORAL Prescription No AB 200909 DR REDDYS LABS SA
    EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;10MG TABLET;ORAL Prescription No AB 208699 GLENMARK PHARMS LTD
    EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;10MG TABLET;ORAL Prescription No AB 202968 WATSON LABS INC
    VYTORIN EZETIMIBE; SIMVASTATIN 10MG;10MG TABLET;ORAL Prescription Yes AB 021687 MSD INTL

    TABLET;ORAL; 10MG;20MG
    TE Code = AB

    Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
    EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;20MG TABLET;ORAL Prescription No AB 209222 ALKEM LABS LTD
    EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;20MG TABLET;ORAL Prescription No AB 208831 AMNEAL PHARMS CO
    EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;20MG TABLET;ORAL Prescription No AB 201890 ANI PHARMS INC
    EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;20MG TABLET;ORAL Prescription No AB 200909 DR REDDYS LABS SA
    EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;20MG TABLET;ORAL Prescription No AB 208699 GLENMARK PHARMS LTD
    EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;20MG TABLET;ORAL Prescription No AB 202968 WATSON LABS INC
    VYTORIN EZETIMIBE; SIMVASTATIN 10MG;20MG TABLET;ORAL Prescription Yes AB 021687 MSD INTL

    TABLET;ORAL; 10MG;40MG
    TE Code = AB

    Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
    EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;40MG TABLET;ORAL Prescription No AB 209222 ALKEM LABS LTD
    EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;40MG TABLET;ORAL Prescription No AB 208831 AMNEAL PHARMS CO
    EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;40MG TABLET;ORAL Prescription No AB 201890 ANI PHARMS INC
    EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;40MG TABLET;ORAL Prescription No AB 200909 DR REDDYS LABS SA
    EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;40MG TABLET;ORAL Prescription No AB 208699 GLENMARK PHARMS LTD
    EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;40MG TABLET;ORAL Prescription No AB 202968 WATSON LABS INC
    VYTORIN EZETIMIBE; SIMVASTATIN 10MG;40MG TABLET;ORAL Prescription Yes AB 021687 MSD INTL

    TABLET;ORAL; 10MG;80MG
    TE Code = AB

    Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
    EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;80MG TABLET;ORAL Prescription No AB 209222 ALKEM LABS LTD
    EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;80MG TABLET;ORAL Prescription No AB 208831 AMNEAL PHARMS CO
    EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;80MG TABLET;ORAL Prescription No AB 201890 ANI PHARMS INC
    EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;80MG TABLET;ORAL Prescription No AB 200909 DR REDDYS LABS SA
    EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;80MG TABLET;ORAL Prescription No AB 208699 GLENMARK PHARMS LTD
    EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;80MG TABLET;ORAL Prescription No AB 202968 WATSON LABS INC
    VYTORIN EZETIMIBE; SIMVASTATIN 10MG;80MG TABLET;ORAL Prescription Yes AB 021687 MSD INTL
    Get the next $ANIP alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ANIP

    DatePrice TargetRatingAnalyst
    3/14/2025$80.00Buy
    Jefferies
    3/12/2025$85.00Overweight
    Analyst
    12/11/2024$80.00Outperform
    Leerink Partners
    10/11/2024$68.00Overweight
    Piper Sandler
    3/15/2024$80.00Overweight
    CapitalOne
    8/22/2023$60.00 → $73.00Buy
    H.C. Wainwright
    3/1/2023$55.00Buy
    Guggenheim
    9/7/2022$50.00Buy
    H.C. Wainwright
    More analyst ratings